Pharm Sciences Lab  

Grants

Laboratory

 

Dr. Anad Iyer

Grantsmanship

Ongoing Research Support

09/2012 - 08/2017
National Cancer Institute (NIH/NCI)
Anti-Tumorigenic Potential of Novel Digitoxin Analogues

  • Role: Principal Investigator

  • Amount: $1.35 Million

09/2011 - 06/2016
National Heart, Lung and Blood Institute (NIH/NHLBI)
Impact of Oxidative Stress-Mediated Angiogenesis in Pulmonary Fibrosis

  • Role: Co-Investigator

  • Amount: $1.3 Million

Completed Research Support

01/2011 - 07/2012
Faculty Development Grant, Hampton University
Anti-Tumorigenic Effects of Novel Digitoxin Analogues

  • Role: Principal Investigator

  • Amount: $5,250

01/2010 - 06/2011
Faculty Development Grant, Hampton University
Elucidation of Novel Signaling Mechanisms in Carbon Nanotube Carcinogenesis

  • Role: Principal Investigator

  • Amount: $5,000

06/2010 - 12/2011
Faculty Development Grant, Hampton University
Angiogenic and Oxidative Stress Mediators in Pulmonary Fibrosis

  • Role: Co-Investigator

  • Amount: $5,300

01/2008 - 01/2009
West Virginia University Research Funding Development Grant
Role of Akt/PKB in Mediating Carbon Nanotube-Induced Pathogenesis

  • Role: Co-Investigator

  • Amount: $25,000

Pending Research Support (Under Review)

01/2012 - 05/2017
National Heart, Lung and Blood Institute (NIH/NHLBI)
The Hampton University Summer Scholars Program in Biomedical Research

  • Role: Program Director

  • Amount: $ 530,000

 

Pharm Sciences Lab

 

www.pharmsciences.com 2014 - 2018